AC Immune Balance Sheet Health
Financial Health criteria checks 6/6
AC Immune has a total shareholder equity of CHF123.4M and total debt of CHF0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CHF237.5M and CHF114.1M respectively.
Key information
0%
Debt to equity ratio
CHF 0
Debt
Interest coverage ratio | n/a |
Cash | CHF 175.12m |
Equity | CHF 123.43m |
Total liabilities | CHF 114.11m |
Total assets | CHF 237.54m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: IMR's short term assets (CHF180.5M) exceed its short term liabilities (CHF100.5M).
Long Term Liabilities: IMR's short term assets (CHF180.5M) exceed its long term liabilities (CHF13.6M).
Debt to Equity History and Analysis
Debt Level: IMR is debt free.
Reducing Debt: IMR has no debt compared to 5 years ago when its debt to equity ratio was 0.2%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable IMR has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: IMR is unprofitable but has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by 18.8% per year.